🔊 [PRESS RELEASE] Théa Open Innovation and Link Biologics, announce the signature today of a partnership to co-develop Link_TSG6 for the treatment of Dry Eye Disease (DED) and other ophthalmology indications. 👁️"This collaboration showcases Théa’s dedication to delivering therapeutic solutions for dry eye conditions, addressing a significant unmet medical need.", says Jean-Frédéric Chibret, President of Théa Group. To read the press release and for more information, link in comment 👇 #Théa #NeverStopLearning #LetsOpenOurEyes #Ophthalmology #Innovation
Monia CHEOUR
1y
Congratulation to Théa and all the team 👏👏👏
https://bit.ly/45PFat4